与芬特明/托皮拉酸相关的不良反应的信号识别:基于FAERS报告的研究
Xinyue Lu1, Yuanyuan Huang1, Lianhong Ji1
1Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China; Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, China; Nanjing University of Chinese Medicine, No. 282 Hanzhong Avenue, Nanjing 210023, China.
芬特明/托皮拉是一种有效的抗肥胖药物,但其安全性需要仔细监测. 这项研究发现了新的不良事件,包括PCOS和暴饮暴食,这些不列在药物中.
科学领域:
- 药监和药物安全 药监和药物安全
- 肥胖治疗方法 肥胖治疗方法
- 临床药理学 临床药理学
背景情况:
- 芬特明/托皮拉是一种高效的抗肥胖药物.
- 了解其全面的安全概况对于临床实践至关重要.
- 现有的数据可能无法捕捉所有潜在的不良事件.
研究的目的:
- 系统地分析与芬特明/托皮拉相关的不良事件 (AE).
- 使用FDA不良事件报告系统 (FAERS) 识别潜在的安全信号.
- 为了为这种抗肥胖疗法提供更安全的临床决策信息.
主要方法:
- 从FAERS (2012年第三季度 - 2024年第四季度) 提取了胺/托皮拉酸AE报告.
- 应用了四种信号检测方法:ROR,PRR,BCPNN和MGPS.
- 分析了23个系统器官类 (SOC) 的5173个AE报告.
主要成果:
- 在所有方法中确定了104个符合信号标准的首选术语 (PT).
- 在眼睛,情感/心理和代谢类别中观察到已知的副作用.
- 检测到新的安全信号,包括多囊卵巢综合征 (PCOS),舌头出血,暴饮暴食和葡萄糖耐受性受损.
结论:
- 芬特明/托皮拉美特显示显著的减肥有效性.
- 药物的不良反应概况是多样化的,包括未列出的事件.
- 由于已识别的安全信号,需要谨慎的临床应用.
更多相关视频
05:10Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
FDA Approved Drugs: Changes to Approved Drugs
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
